CX3CL1 and infection: This large observational study suggests that plasma fractalkine, while not specific for infection, is a sustained biomarker of disease severity and outcome in sepsis patients admitted to the ICU, irrespective of the primary source of infection and is likely derived from the activated vascular endothelium.